Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Characterizing cellular senescence to prevent retinal ganglion cell loss in glaucoma

Chris Louche; Praveena Manogaran; Nadine Colé; Peter Westenskow; Joana Galvao

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):930 – A0399.

ARVO Annual Meeting Abstract June 2021

VEGF-A/Ang-2 neutralization causes sustained prevention of subretinal macrophage infiltration in a mouse model of spontaneous choroidal neovascularization

Jérémie Canonica; Sabine Uhles; Richard Foxton; Nadine Cole; Mirjana Lazendic; Marina Garcia Garrido; Peter Westenskow

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):274.

ARVO Annual Meeting Abstract June 2020

Sustained Vessel Stabilization Through Targeting Angiopoietin-2 (Ang-2) With Faricimab, a Bispecific Antibody Neutralizing Both Ang-2 and Vascular Endothelial Growth Factor A (VEGF-A)

Usha Chakravarthy; Richard Foxton; Sabine Uhles; Nadine Cole; Franco Revelant; Jayashree Sahni; Hugh Lin; Stefan Scheidl; Christoph Ullmer; Sascha Fauser

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5126.

ARVO Annual Meeting Abstract July 2018

Evaluation of the effects of VEGF/ANG-2 neutralization on vascular, neuronal and inflammatory pathologies in a spontaneous choroidal neovascularization (CNV) mouse model

Richard H Foxton; Sabine Uhles; Sabine Gruener; Franco Revelant; Nadine Colé; Mirjana Lazendic; Mathieu Brecheisen; Christoph Ullmer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):237.

ARVO Annual Meeting Abstract June 2017

Real-time measurements of vascular permeability in the mouse eye using vitreous fluorophotometry

Richard Foxton; Ashwath Jayagopal; Nadine Colé

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2030.

Advertisement